Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose 6-way crossover study of inhaled AZD2115 versus placebo and active comparators in COPD
2011-004641-41Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of azd2115 in chronic obstructive pulmonary disease (COPD), sponsored by AstraZeneca. Started Dec 2011; status: completed.
02
Drugs
azd2115
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2011-004641-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004641-41.